ID

24713

Descrição

Microvascular Coronary Disease In Women: Impact Of Ranolazine; ODM derived from: https://clinicaltrials.gov/show/NCT00570089

Link

https://clinicaltrials.gov/show/NCT00570089

Palavras-chave

Versões (1)
  1. 14/08/2017 14/08/2017 -
Transferido a

14 de agosto de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

  • Os mais recentes
  • Os mais antigos
  • Preferidos
  • Os mais recentes
    • Os mais recentes
    • Os mais antigos
    • Preferidos

Sem comentários

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Myocardial Ischemia NCT00570089

Inglês

Eligibility Myocardial Ischemia NCT00570089

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. women with signs and symptoms of myocardial ischemia (chest pain, abnormal stress testing, abnormal noninvasive testing) in the absence of obstructive coronary artery disease (epicardial coronary stenosis <50% luminal diameter stenosis).
Descrição

Gender | Signs and Symptoms Myocardial Ischemia | Chest Pain | Cardiac stress test abnormal | Testing Noninvasive Abnormal | Coronary Artery Disease Obstructive Absent | Coronary Stenosis Epicardial | Percent Diameter Stenosis Measurement Luminal

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0037088
UMLS CUI [2,2]
C0151744
UMLS CUI [3]
C0008031
UMLS CUI [4]
C1096350
UMLS CUI [5,1]
C0039593
UMLS CUI [5,2]
C2986496
UMLS CUI [5,3]
C0205161
UMLS CUI [6,1]
C1956346
UMLS CUI [6,2]
C0549186
UMLS CUI [6,3]
C0332197
UMLS CUI [7,1]
C0242231
UMLS CUI [7,2]
C0442016
UMLS CUI [8,1]
C3897965
UMLS CUI [8,2]
C0524462
2. women with ≥10% myocardial ischemia by cmr perfusion.
Descrição

Gender | Myocardial Ischemia Percentage | Cardiovascular magnetic resonance imaging Perfusion

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0151744
UMLS CUI [2,2]
C0439165
UMLS CUI [3,1]
C3873775
UMLS CUI [3,2]
C0428857
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. contraindications to withholding nitrates, beta-blockers, calcium channel agents, ace/arb agents for 48 hours prior to testing.
Descrição

Medical contraindication Nitrates | Medical contraindication Adrenergic beta-Antagonists | Medical contraindication Calcium Channel Blockers | Medical contraindication Angiotensin-Converting Enzyme Inhibitors | Medical contraindication Angiotensin II receptor antagonist

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0028125
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0001645
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0006684
UMLS CUI [4,1]
C1301624
UMLS CUI [4,2]
C0003015
UMLS CUI [5,1]
C1301624
UMLS CUI [5,2]
C0521942
2. contraindications in cmr including aicd, pacemaker, untreatable claustrophobia or known angio-edema.
Descrição

Medical contraindication Cardiovascular magnetic resonance imaging | Automatic Implantable Cardioverter-Defibrillators | Artificial cardiac pacemaker | Claustrophobia Treating Unsuccessful | Angioedema

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C3873775
UMLS CUI [2]
C0972395
UMLS CUI [3]
C0030163
UMLS CUI [4,1]
C0008909
UMLS CUI [4,2]
C1522326
UMLS CUI [4,3]
C1272705
UMLS CUI [5]
C0002994
3. contraindications to ranolazine including hepatic insufficiency, prolonged qt, renal failure.
Descrição

Medical contraindication ranolazine | Hepatic Insufficiency | Prolonged QT interval | Kidney Failure

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0073633
UMLS CUI [2]
C1306571
UMLS CUI [3]
C0151878
UMLS CUI [4]
C0035078
4. women taking drugs that inhibit cyp3a such as diltiazem, verapamil, ketoconazole, macrolides or hiv protease inhibitors.
Descrição

Gender | CYP3A Inhibitors | Diltiazem | Verapamil | Ketoconazole | Macrolides | HIV Protease Inhibitors

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C3850056
UMLS CUI [3]
C0012373
UMLS CUI [4]
C0042523
UMLS CUI [5]
C0022625
UMLS CUI [6]
C0282563
UMLS CUI [7]
C0162714
5. women less than 18 years of age.
Descrição

Gender | Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
6. women on drugs that prolong the qt interval such as class ia or iii antiarrhythmic agents, erythromycin, certain antipsychotics.
Descrição

Gender | Pharmaceutical Preparations Causing Prolonged QT interval | Anti-Arrhythmia Agents Class | Erythromycin | Antipsychotic Agents

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0678227
UMLS CUI [2,3]
C0151878
UMLS CUI [3,1]
C0003195
UMLS CUI [3,2]
C0456387
UMLS CUI [4]
C0014806
UMLS CUI [5]
C0040615
7. pregnancy or breast feeding.
Descrição

Pregnancy | Breast Feeding

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
8. life expectancy less than 6 months.
Descrição

Life Expectancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023671
Voltar ao início da página

Similar models

Eligibility Myocardial Ischemia NCT00570089

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Signs and Symptoms Myocardial Ischemia | Chest Pain | Cardiac stress test abnormal | Testing Noninvasive Abnormal | Coronary Artery Disease Obstructive Absent | Coronary Stenosis Epicardial | Percent Diameter Stenosis Measurement Luminal
Item
1. women with signs and symptoms of myocardial ischemia (chest pain, abnormal stress testing, abnormal noninvasive testing) in the absence of obstructive coronary artery disease (epicardial coronary stenosis <50% luminal diameter stenosis).
boolean
C0079399 (UMLS CUI [1])
C0037088 (UMLS CUI [2,1])
C0151744 (UMLS CUI [2,2])
C0008031 (UMLS CUI [3])
C1096350 (UMLS CUI [4])
C0039593 (UMLS CUI [5,1])
C2986496 (UMLS CUI [5,2])
C0205161 (UMLS CUI [5,3])
C1956346 (UMLS CUI [6,1])
C0549186 (UMLS CUI [6,2])
C0332197 (UMLS CUI [6,3])
C0242231 (UMLS CUI [7,1])
C0442016 (UMLS CUI [7,2])
C3897965 (UMLS CUI [8,1])
C0524462 (UMLS CUI [8,2])
Gender | Myocardial Ischemia Percentage | Cardiovascular magnetic resonance imaging Perfusion
Item
2. women with ≥10% myocardial ischemia by cmr perfusion.
boolean
C0079399 (UMLS CUI [1])
C0151744 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C3873775 (UMLS CUI [3,1])
C0428857 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Nitrates | Medical contraindication Adrenergic beta-Antagonists | Medical contraindication Calcium Channel Blockers | Medical contraindication Angiotensin-Converting Enzyme Inhibitors | Medical contraindication Angiotensin II receptor antagonist
Item
1. contraindications to withholding nitrates, beta-blockers, calcium channel agents, ace/arb agents for 48 hours prior to testing.
boolean
C1301624 (UMLS CUI [1,1])
C0028125 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0001645 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0006684 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0003015 (UMLS CUI [4,2])
C1301624 (UMLS CUI [5,1])
C0521942 (UMLS CUI [5,2])
Medical contraindication Cardiovascular magnetic resonance imaging | Automatic Implantable Cardioverter-Defibrillators | Artificial cardiac pacemaker | Claustrophobia Treating Unsuccessful | Angioedema
Item
2. contraindications in cmr including aicd, pacemaker, untreatable claustrophobia or known angio-edema.
boolean
C1301624 (UMLS CUI [1,1])
C3873775 (UMLS CUI [1,2])
C0972395 (UMLS CUI [2])
C0030163 (UMLS CUI [3])
C0008909 (UMLS CUI [4,1])
C1522326 (UMLS CUI [4,2])
C1272705 (UMLS CUI [4,3])
C0002994 (UMLS CUI [5])
Medical contraindication ranolazine | Hepatic Insufficiency | Prolonged QT interval | Kidney Failure
Item
3. contraindications to ranolazine including hepatic insufficiency, prolonged qt, renal failure.
boolean
C1301624 (UMLS CUI [1,1])
C0073633 (UMLS CUI [1,2])
C1306571 (UMLS CUI [2])
C0151878 (UMLS CUI [3])
C0035078 (UMLS CUI [4])
Gender | CYP3A Inhibitors | Diltiazem | Verapamil | Ketoconazole | Macrolides | HIV Protease Inhibitors
Item
4. women taking drugs that inhibit cyp3a such as diltiazem, verapamil, ketoconazole, macrolides or hiv protease inhibitors.
boolean
C0079399 (UMLS CUI [1])
C3850056 (UMLS CUI [2])
C0012373 (UMLS CUI [3])
C0042523 (UMLS CUI [4])
C0022625 (UMLS CUI [5])
C0282563 (UMLS CUI [6])
C0162714 (UMLS CUI [7])
Gender | Age
Item
5. women less than 18 years of age.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Gender | Pharmaceutical Preparations Causing Prolonged QT interval | Anti-Arrhythmia Agents Class | Erythromycin | Antipsychotic Agents
Item
6. women on drugs that prolong the qt interval such as class ia or iii antiarrhythmic agents, erythromycin, certain antipsychotics.
boolean
C0079399 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0678227 (UMLS CUI [2,2])
C0151878 (UMLS CUI [2,3])
C0003195 (UMLS CUI [3,1])
C0456387 (UMLS CUI [3,2])
C0014806 (UMLS CUI [4])
C0040615 (UMLS CUI [5])
Pregnancy | Breast Feeding
Item
7. pregnancy or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Life Expectancy
Item
8. life expectancy less than 6 months.
boolean
C0023671 (UMLS CUI [1])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial